Showing results (531-540 of 2,388) with videos related to
Sort By:
Pageof 239
Digestive Diseases (Basel, Switzerland)|August 22, 2018
Efficacy and Safety of Infliximab Tolerance Induction in Patients with Inflammatory Bowel Diseases who Experienced Acute Infusion ReactionsIsabelle Pauchard, Stéphane Nancey, Florence Hacard, et al.Digestive Diseases (Basel, Switzerland)|August 28, 2018
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's DiseaseBelén Beltrán, Marisa Iborra, Esteban Sáez-González, et al.Digestive Diseases (Basel, Switzerland)|October 19, 2012
Animal models for autoimmune liver disease--what is relevant for immune-mediated liver diseaseMatthias Hardtke-Wolenski, Richard Taubert, Elmar JaeckelDigestive Diseases (Basel, Switzerland)|October 19, 2012
NK cells in hepatitis C: role in disease susceptibility and therapySebastian Lunemann, Verena Schlaphoff, Markus Cornberg, et al.Digestive Diseases (Basel, Switzerland)|October 19, 2012
The genetics universe of Crohn's disease and ulcerative colitisMiles ParkesDigestive Diseases (Basel, Switzerland)|June 23, 2012
The role of obesity in gastroesophageal reflux disease and Barrett's esophagusLeonardo Henry Eusebi, Lorenzo Fuccio, Franco BazzoliDigestive Diseases (Basel, Switzerland)|June 23, 2012
Targets for medical therapy in obesityMaja BaretićDigestive Diseases (Basel, Switzerland)|June 23, 2012
Diagnosis and treatment of autoimmune hepatitisJan LataDigestive Diseases (Basel, Switzerland)|June 23, 2012
Extraintestinal manifestations of autoimmune pancreatitisTomica Milosavljevic, Mirjana Kostic-Milosavljevic, Ivan Jovanovic, et al.Digestive Diseases (Basel, Switzerland)|June 23, 2012
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challengesAnna Giacomin, Adriana Sergio, Veronica Vanin, et al.Pageof 239